Absci Corporation Taps Advanced Micro Devices Inc. (AMD) Chip for AI Drug Discovery Platform

Advanced Micro Devices Inc. (NASDAQ:AMD) is one of the best tech stocks to buy, according to Cathie Wood. On September 11, Absci Corporation (ABSI), a clinical-stage biotechnology firm, announced a strategic partnership with Oracle Cloud Infrastructure and Advanced Micro Devices Inc. to advance its AI-powered drug discovery platform.

Under the terms of the agreement, Absci is to leverage AMD’s 5th Generation EPYC processor and RDMA cluster network to develop an AI-driven drug discovery platform. The integration will enable Absci to leverage low-latency networking and high-throughput capabilities, while also enhancing platform performance and scalability.

“Our mission is to push the boundaries of how we design new therapeutics,” said Sean McClain, Founder and CEO of Absci. “With OCI and AMD, we are pairing our cutting-edge AI models with best-in-class infrastructure.”

Advanced Micro Devices Inc. (NASDAQ:AMD) is a semiconductor company that designs high-performance and adaptive computing technologies, including CPUs, GPUs, and FPGAs, for various sectors such as PCs, data centers, gaming, and embedded systems. Its products power artificial intelligence, supercomputing, cloud computing, and entertainment.

While we acknowledge the potential of AMD as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 13 Best Tech Stocks to Buy for the Long Term and 9 Green Energy Stocks with Long-Term Upside Potential.

Disclosure: None. This article is originally published at Insider Monkey.